Alfred D. Kingsley, Director at Oncocyte Corp (OCX), bought 25,000 shares at $0.29 ($7K) on 2022-12-22, disclosed to the SEC on 2022-12-27.
Open-market purchase of $7k OCX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| OCX | SELL | 2020-12-28 | $2K | — | Filing → |
| OCX | SELL | 2020-12-23 | $13K | — | Filing → |
| BTX | SELL | 2017-08-02 | $420K | — | Filing → |